Evidence map›Paper›PMID 39911128›Full record

ArticleHaematologica2025

Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02).

Sarah Bertoli, Emilie Bérard, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Yosr Hicheri, Omar Benbrahim, Martin Carre, Corentin Orvain, Anne Banos and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Cross-Talk Between Histamine HPharmacology research & perspectives · 2026
    Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Sarah BertoliService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Emilie BérardService d'Epidémiologie, Centre Hospitalier Universitaire de Toulouse, CERPOP, Inserm, Université Toulouse III Paul Sabatier, Toulouse.
Pierre PeterlinService d'Hématologie, Centre Hospitalier Universitaire de Nantes.
Romain GuiezeService d'Hématologie clinique et de thérapie cellulaire, Centre Hospitalier Universitaire de Clermont-Ferrand.
Yohan DesbrossesService d'Hématologie, Centre Hospitalier Universitaire de Besançon.
Yosr HicheriDépartement d'Hématologie, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille.
Omar BenbrahimService d'Hématologie, Centre Hospitalier d'Orléans.
Martin CarreService d'Hématologie, Centre Hospitalier Universitaire de Grenoble.
Corentin OrvainMaladies du Sang, CHU d'Angers, Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, FHU-GOAL, Université d'Angers, Inserm UMR 1307, CNRS UMR 6075, Nantes Université, CRCI2NA, Angers.
Anne BanosService d'Hématologie, Centre Hospitalier de la Côte Basque, Bayonne.
Marc BernardService d'Hématologie, Centre Hospitalier Universitaire de Rennes.
Emmanuel GyanService d'Hématologie, Centre Hospitalier Universitaire de Tours.
Alain SaadService d'Hématologie, Centre Hospitalier de Béziers.
Safia ChebrekService d'Onco-Hématologie, Centre Hospitalier d'Avignon.
Gabrielle Roth GuepinService d'Hématologie, Centre Hospitalier Universitaire de Nancy.
Veronique DorvauxService d'Hématologie, Centre Hospitalier de Metz.
Laurence SanhesService d'Hématologie, Centre Hospitalier de Perpignan.
Maria Pilar Gallego-HernanzService d'Hématologie, Centre Hospitalier Universitaire de Poitiers.
Carole ExbrayatService d'Hématologie, Clinique du Parc, Castelnau-le-Lez.
Laure VincentService d'Hématologie, Centre Hospitalier Universitaire de Montpellier.
Chantal HimberlinService d'Hématologie, Centre Hospitalier Universitaire de Reims.
Célestine SimandService d'Hématologie, Centre Hospitalier Universitaire de Strasbourg.
Norbert VeyDépartement d'Hématologie, Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille.
Cindy FenollFrench Innovative Leukemia Organisation, Hôpital Bretonneau, Tours.
Ariane MineurFrench Innovative Leukemia Organisation, Hôpital Bretonneau, Tours.
Anne HuynhService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Francois VergezLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Isabelle LuquetLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Laetitia LargeaudLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Eric DelabesseLaboratoire d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse.
Arnaud PigneuxService d'Hématologie Clinique et de Thérapie Cellulaire, Centre Hospitalier Universitaire de Bordeaux.
Christian RécherService d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. recher.christian@iuct-oncopole.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39911128
PMCPMC12485338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.